The continued evolution of biomedical nanotechnology has enabled clinicians to better
detect, prevent, manage, and treat human disease. In order to further push the limits of …

Advanced drug delivery systems (DDS) enhance treatment efficacy of different therapeutics
in a dosage, spatial, and/or temporal controlled manner. To date, numerous chemical-or …

Cardiovascular disease (CVD), which encompasses a number of conditions that can affect
the heart and blood vessels, presents a major challenge for modern-day healthcare. Nearly …

Nanoparticles (NPs) are emerging as promising carrier platforms for targeted drug delivery
and imaging probes. To evaluate the delivery efficiency, it is important to predict the …

Cell membrane-derived nanoparticles (NPs) have recently gained popularity due to their
desirable features in drug delivery such as mimicking properties of native cells, impeding …

Platelets, circulating blood cells derived from megakaryocytes, play a key role in various
physical activities, including coagulation, hemostasis, the body's innate immune response …

Background Traditional nanoparticle-based drug delivery systems suffer from several
limitations, such as easy clearance from blood and inaccurate targeting. Materials and …

The development of new and improved particle-based drug delivery is underpinned by an
enhanced ability to engineer particles with high fidelity and integrity, as well as increased …

Nanotechnology is proven to provide certain benefits in drug delivery by improving solubility,
increasing uptake to target sites and changing pharmacokinetics profiles of traditional drugs …

Human endothelial cells are initiators and targets of the rejection response. Pre-operative
modification of endothelial cells by small interfering RNA transfection could shape the nature …